
Plenary Session
A podcast about medicine, oncology, and health policy. Hosted by Vinay Prasad, MD MPH from the University of California, San Francisco. The show invites listeners to share feedback on Twitter or via email.
Episodes
5.05 Measles in PA, Nature's editorial, and more
5.05 Measles in PA, Nature's editorial, and more by Plenary Session
5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards
5.04 Jason Arday, Nathan Cofnas and the Decline of University Standards by Plenary Session
5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin
5.03 - 5 red flags, Betting Markets, Covid Czar says lab origin by Plenary Session
Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony
Season 5 Ep 2 - Anthony Fauci's Diary and Congressional Testimony by Plenary Session

Reboot - I am back with Audio podcasts
Reboot - I am back with Audio podcasts by Plenary Session
Longevity Episode 2 - Nutrition science
Longevity Episode 2 - Nutrition science by Plenary Session
Longevity Lecture series Introduction and Lecture 1
Longevity Lecture series Introduction and Lecture 1 by Plenary Session
CABINET - trial - Cabozantinib for NET
Back to basics as I break down a trial
RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom
I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya.
Trump is breaking media brains / NIH cuts indirect payments and scientists freak out
I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.
Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints
I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.
Why the NIH is a broken funding system
I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.
CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!
I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.
Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!
I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!
The ENTIRE healthcare system is broken, not just health insurance companies
The entire healthcare system is broken, it's not just health insurance companies.
Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits
Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.
2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More
Our 2 hour critical appraisal and ASH review.
SO many guest stars
Systematic Reviews - An Introduction⧸ How to do them⧸ Search Strategies⧸ Common Errors
Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.
Special post-ESMO 2024 edition !
Timothee Olivier and I discuss the top ESMO 2024 abstracts!
Artificial Intelligence in Medicine - My Keynote
AI in healthcare - my latest keynote address
Masking Mistakes - my panel discussion at the Emory Center for Ethics
"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics program.
How We Can Do Better As A County Hospital
Screening/ Drug efficacy/ Sotorasib/ Adaura and more
Driver mutation lung cancer - My lecture
My UCSF lecture on driver mutation lung cancer
Post ASCO wrap up with Timothee Olivier
We break down the best studies from ASCO
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session
Asco Prequel - We talk about what to look for
What you need to know in advance of ASCO
A SM crossover - Cifu, Prasad, Mandrola
Should trials have carbon footprint as an endpoint?
When Evidence EXPIRES - My Grand Rounds Today at Mt Sinai
My grand rounds; Beta blockers post MI
Single center vs multicenter RCT
Masks
Boosters and more
Cifu, Mandrola, Prasad - SM crossover
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year
Patient advocates funded by Pharma
Patient advocates, Pharma funding, and is MRD a suitable endpoint
FDA makes MRD the basis for AA
5 reasons that is a bad idea
Beta Blockers After Heart Attacks Don't Work
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".
Blood based and Stool DNA colon cancer screening - Two NEJM papers
They are shitty
Keynote 564 - a flawed study
Another flawed study Keynote 564. Pembro in adjuvant RCC
CONTACT-01 Cabo/ Atezo in Prostate Cancer - An Unethical trial
What happens when doctors run unethical studies?
CAR T causes MDS??? Manni, Goodman, Raj, Prasad
Does car T cause secondary AML?
We discuss
Timothee and Prasad talk 2023 cancer trials
We talk about 2023 cancer trials
Aaron Goodman Prasad ASH UPDATES
Goodman and I discuss ash updates.
My myeloma talk
https://www.youtube.com/watch?v=jAz84yCnfjQ
Mandrola and Prasad
Subscribe to Sensible Med Pod; This is x over
Post partum depression, orbita 2 and physics vs medicine
COVID19 Policy: What the US Got Wrong
My Lecture in Curacao 4/4
Vaccines, Masks, Mandates, Lockdowns, School closure
Other lectures to come
Lecture 1 of 4 Curacao - How to Keep Up with Literature
Entresto, Lung Transplants, How to Keep Up with Literature - Lecture to Trainees in Curacao
Advice Pre-Med Students | Lecture at UC Berkeley
This is a lecture I gave on November 5, 2023, to pre-medicine undergraduate students at University of California Berkeley.
Radiation oncology in GI malignancy - Nina Sanford and Bill Hall
Radiation oncology in GI malignancy (endpoints and stratification) in the JCO
Hawai Keynote - Coffee and colon cancer & Censoring & More
Prasad is back in Hawaii to give another keynote (good thing they cancelled Dallas not Honolulu). I discuss coffee and colon cancer, and censoring, and Lu177 PSMA
Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3
This is a lecture I gave on ethics and institutional review boards in Denmark in September 2023. It is the last of the three lectures I gave.
Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover
Mandrola, Prasad and Cifu are back to discuss the latest drama
The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3
This is a lecture I gave on the state of immunotherapy in oncology at the Immunotherapy Symposium In Denmark in September 2023. It is the second of three lectures I gave.
Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3
The first of the three lectures I gave in Denmark in September 2023 was on the medical evidence behind decision-making by health technology assessment groups.
Great And Crazy Things We Do In Medicine
This is the live recording of a talk given on the great and crazy things we do in medicine, from cancer drugs to boosters and more.
Fixing Cancer Medicine w/ Timothee Olivier
Timothee is back to discuss Malignant and Solutions
Coumadin, ECMO, RCTs and more
A far reaching discussion btw Mandrola and Prasad on RCTs, Coumadin, ECMO and RCTs for covid shots
Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting
Simultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast.
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
Testosterone/ Should Scientists Debate/ Mike Joyner
A sensible medicine crossover episode
Follow the sensible medicine podcast feed for more of these discussions
Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP
T. Olivier from Geneva is back. A fan favorite guest. We discuss 3 recent papers.
ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL
Researchers were too busy counting dead bodies to give the control arm appropriate therapy when their cancer recurred. Disgusting conduct.
I break down ADAURA
OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper
Mike Putman, Todd C. Lee, John Mandrola and I debate the recent JAMA paper on RCT Duplicate. This is a spirited round table discussion on the limitations of observational data. If you are reading this, leave a comment as a review!
Myeloma Roundtable - Manni M. Raj C. VP discuss controversies
Early treatment of myeloma, dual vs. single maintenance, and finally transplant or no transplant.
Mammographic Screening : A complete review of the evidence
Why the USPSTF is wrong
The Crushing, Cruel Cost of Cancer Drugs - My Lecture
Cost of Cancer drugs - VP's lecture
Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky
I combine two latest tracks on interpreting medical studies, medical boards, 7 doses of vaccine, and finally Walensky. Stay tuned.
Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad
We explore the fight btw NYTimes, Cochrane, and the last people keeping EBM alive
Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself
Zeb joins me for the 7th time to discuss all the key pandemic questions
Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals
My lecture to Harvard regulatory science
5.47 - Real World Evidence - Keynote Lecture in Denmark
VP goes to Denmark to give the keynote at the Danish medical association conference
5.46 - What is Science: reflections on the field
What is science?
5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care
Karmma 3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor
More basics on randomized controlled trials - Part 2
I get into endpoints, surrogates, validation, blinding, crossover, and control arms.
RCT 101 And Papa Heme
I talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more. Then Papa Heme Tells you How to Find your First Job
Tom Newman And VP Discuss Public Health
Dr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time.
5.41 - Michael Putman MCW debates me on recent policy Qs
Mike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more.
Sensible Med Superbowl Plenary Session Crossover
A new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer
5.39 - Sotorasib and Codebreak 200
I destroy the trial. Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can.
Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise
I annotate an online case discussion; Every decision is not based in evidence. Madness
5.37 - Keynote Lecture on Physician Burnout
This lecture on Burnout will not be like any other you have heard
5.36 - ASH UPDATE #4 - GEM CESAR
I break down the GEM CESAR trial
K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer
What a crazy trial!
5.35 - ASH Update #3 - the Ascent Trial
This uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative. Sad day for oncology
5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed
Sample size games, primary endpoint, head to head trials in oncology
Rate this podcast on itunes
Coming next is Triangle trial
5.33 USC Grand Rounds Hematology
Grand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed)
More ASH coming soon
5.32 - ASH Update #1 - Talquetamab NEJM
Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
Recommended

Learn English B1 with Daily News | English Listening Practice

Talk About Talk - Executive & Leadership Communication Skills

English with Olivia | Slow Conversations & Vocabulary

Stand In The Circle

SLOW ENGLISH PODCAST (A1-A2) With Subtitles | Daily Videos | English With Us Podcast

Learn English A2 with Daily News | Simple English Listening Practice

پلی لیست | PlayList

Conspiracy Files with Paige Carter

Bad Friends

Learn 50 English Phrases While You Sleep | Everyday English Phrases & Vocabulary

This Past Weekend w/ Theo Von

Dateline NBC